Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

01 December 2007

Tacrolimus – biotechnological prospects for a generic product

W. Gajzlerska, J. Turło, B. Gutkowska, F. Herold

Ann Transplant 2008; 13(1): 40-41 :: ID: 880205

Abstract

Background: Tacrolimus, an immunosuppressive calcineurin inhibitor, is widely used in transplantation, as well as in dermatology and invasive cardiology. This drug, first discovered as the product of Streptomyces tsukubaensis, is isolated from the whole fermentation broth of these bacteria cultivated in submerged culture strain. The aim of our research was to optimize the process of tacrolimus biosynthesis by means of submerged cultivation using liquid media containing by or waste- products of food industry. The next goal was to examine the influence of C3 effectors such as propanol, propylene glycol and propionic acid on productivity of the biosynthesis process.
Materials/Methods: The Streptomyces tsukubaensis strain (FERM BP-927) was used to investigate the relationships between the composition of the cultivation medium, the mycelial growth and tacrolimus production. Furthermore, the cultures were enriched with propanol, propylene glycol and propionic acid, used as biosynthesis precursors.
Results: The productivity of tacrolimus by the strain is proportional to the mycelial growth. The highest productivity recorded for medium composed in-part of waste products of food industry and not enriched in precursors was approximately 12 μg/mL, and thus approximates the productivity declared in Okuhara et al's US patent. The addition of the biosynthesis precursors, propanol, propylene glycol and propionic acid results in about 3-fold higher biosynthesis productivity. The highest productivity was obtained when
propylene glycol was used.
Conclusions: There is a strong correlation between the composition of the tested media and the strain productivity. Propanol, propylene glycol and propionic acid exert an inducing effect on tacrolimus biosynthesis.

Keywords: Tacrolimus, P. mirabilis, propanol

0 Comments

In Press

04 Aug 2022 : Original article  

Long-Term Patency of All-in-One Sleeve Patch Graft Venoplasty in 16 Patients Who Underwent Living Donor Liv...

Ann Transplant In Press; DOI: 10.12659/AOT.936888  

22 Jul 2022 : Original article  

Diagnostic Role of Tumor Markers for Hepatocellular Carcinoma in Liver Transplantation Candidates: An Analy...

Ann Transplant In Press; DOI: 10.12659/AOT.936937  

22 Jul 2022 : Original article  

Development of a Novel Model for Predicting Postoperative Short-Term Outcome in Patients with Hepatitis B-R...

Ann Transplant In Press; DOI: 10.12659/AOT.936732  

22 Jul 2022 : Original article  

Leucine-Rich Alpha-2-Glycoprotein (LRG-1) as a Potential Kidney Injury Marker in Kidney Transplant Recipients

Ann Transplant In Press; DOI: 10.12659/AOT.936751  

Most Viewed Current Articles

26 Jan 2022 : Review article  

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models

DOI :10.12659/AOT.934924

Ann Transplant 2022; 27:e934924

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

24 Jul 2020 : Review article  

Kidney Transplantation in the Times of COVID-19 – A Literature Review

DOI :10.12659/AOT.925755

Ann Transplant 2020; 25:e925755

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358